Search the Newsroom
Filter By
Showing 981 - 990 of 2781 results
Researchers Point to Need for Implementation Science in Pediatric Oncology
CHOP researchers have found that implementation science is underused in pediatric oncology and call for more research in this area to improve patient care.
Case Study: Aquadex FlexFlow Provides Renal Support as Bridge to Peritoneal Dialysis
Our case study shows the benefits of using the Aquadex FlexFlow® circuit for ultrafiltration or modified continuous veno-venous hemofiltration.
CHOP Study Finds Infants with Low-Risk Deliveries Should Not Need Antibiotics at Birth
CHOP researchers have found infants born via uncomplicated cesarean delivery should not need antibiotics at birth to prevent early-onset sepsis.
International Observerships at CHOP Resume
International observerships, which were halted by the COVID-19 pandemic, officially resumed at Children’s Hospital of Philadelphia in July 2021 when we welcomed 11 healthcare professionals to our program.
Two Girls, Two Cured Cases
Summer 2021 saw the Congenital Hyperinsulinism Center at Children’s Hospital of Philadelphia care for two newborn girls who had the focal form of hyperinsulinism (HI).
Stress of Returning to In-Person Learning Contributes to Mental Health Crisis
The transition from virtual to in-person schooling has taken a toll on young people’s mental health.
CHOP Study Finds Poverty Affects Risk of Cleft Lip and Cleft Palate
CHOP researchers have found that indicators of lower socioeconomic status are associated with an increased risk of cleft lip with or without cleft palate.
Meet Diva De León-Crutchlow, MD, MSCE
Diva De León-Crutchlow, MD, MSCE, assumed the role of Director of the Congenital Hyperinsulinism Center in 2013 and was named Chief of the Division of Endocrinology and Diabetes in 2018.
Children’s Hospital of Philadelphia Appoints New Chief of Hematology
Alexis Anne Thompson, MD, to fulfill new leadership role, bringing with her expertise in blood disorders and clinical practice.
Aberrant Splicing of CD22 in Acute Lymphoblastic Leukemia Underlies Resistance to Immunotherapy
Aberrant splicing leads to downregulation of CD22 in pediatric B-ALL, rendering malignant cells resistant to the effects of CD22-directed immunotherapies.